Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Cancer of Rectum: early-phase trial registry

1 of 2 indexed Cancer of Rectum trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · 1 currently recruiting · #7,188 of 28,707 conditions by registered trial count

Cancer of Rectum: 2 US clinical trials tracked, 1 recruiting.

Cancer of Rectum is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Massive Bio, running 1 of these trials.

Enrollment posture brief

Registry condition cancer-of-rectum

OPEN 1 | RECR 50% | LATE 0 | EARLY 1 | RANK #7188 | SPON 1

Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Cancer of Rectum (this)50%
Open-enrollment share among volume-matched conditions near Cancer of Rectum

Cancer of Rectum lists 1 open slots (50% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Cancer of Rectum on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Cancer of Rectum is recruiting above its size-band peers.

    1 of 2 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 21

Phase Distribution

PhaseTrial count
Phase 2 1

Top Sponsors

Named interventions

Most-linked intervention names on Cancer of Rectum records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Clinical Trial Matching Other
1 trials
Radiation Radiation
1 trials
Oxaliplatin Drug
1 trials
Leucovorin Drug
1 trials
Fluorouracil Drug
1 trials

US sites by state

Facility locations filed on Cancer of Rectum trials. A trial with sites in several states counts in each.

Missouri 1 trials
Georgia 1 trials
Florida 1 trials
Delaware 1 trials
Connecticut 1 trials
Colorado 1 trials
California 1 trials
Arizona 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Cancer of Rectum page

2 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Cancer of Rectum trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Massive Bio sponsors the most Cancer of Rectum trials on record, review their full trial history before evaluating a specific study. See Massive Bio's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Cancer of Rectum condition card totals 2 registered trials; most-linked intervention Clinical Trial Matching; top US site state Missouri. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.